Subject number | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cancer | Esoph. | CCA | Rectal | Esoph. | CCA | Pancr. | Gist | Colon | CCA | Coecum +Ovar. | Pancr. | Pancr. | Bile duct | Rectal | Bile duct | pCCC |
Surgery blood (mL) Dilution fluid (mL) | 1400 550 | 500 0 | 2800 2500 | 1600 1000 | 1100 500 | 1600 500 | 800 300 | 950 300 | 1000 700 | 2200 200 + 800 | 800 150 | 1700 1400 | 1661 900 | 2600 50 | 1400 100 | 800 200 |
EC after LDF, residual Ab (pg/mL) | BLQ | 1694 | BLQ | BLQ | 205.0 | BLQ | 1026 | 491.0 | ND | 252.0 | BLQ | 888.0 | 628.0 | BLQ | 160.0 | BLQ |
Ab total (ng) | BLQ | 69.0 | BLQ | BLQ | 13.0 | BLQ | 68.0 | 22.0 | BLQ | 27.0 | BLQ | 59.0 | 26.0 | BLQ | 9.0 | BLQ |
Vol. EC (mL) | 142.0 | 76.0 | 150.0 | 98.0 | 97.0 | 187.0 | 101.0 | 80.0 | 70.0 | 141.0 | 75.0 | 101.0 | 77.0 | 373.0 | 133.0 | – |
Vol. EC post LDF (mL) | 107.0 | 41.0 | 115.0 | 63.0 | 62.0 | 152.0 | 66.0 | 45.0 | 35.0 | 106.0 | 40.0 | 66.0 | 42.0 | 320.0 | 60.0 | 200.0 |
Amount of applied antibody (μg) | 5.0 | 2.5 | 2.5 | 2.5 | 2.5 | 5.0 | 2.5 | 2.5 | – | 5.0 | 2.5 | 5.0 | 5.0 | 5.0 | 2.5 | 2.5 |